Talazoparib,Enzalutamide
Pfizer,Astellas
[]
significant benefit in in rpfs in hrr+ cohort. #asco2023 #asco23 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.